Literature DB >> 11904757

Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation.

Jillian J Kril1, Smita Patel, Antony J Harding, Glenda M Halliday.   

Abstract

Neurofibrillary tangle (NFT) formation in the CA1 region of the hippocampus is one of the early events in the pathogenesis of Alzheimer's disease (AD). As the disease progresses more NFTs form and there is substantial neuron loss. In this study we investigated whether NFT formation accounts for all the CA1 pyramidal neuron loss seen in AD. Using unbiased stereological techniques, we estimated the total number of neurons and the number of intra- and extra-cellular NFTs in the hippocampus of 10 patients with AD and 10 age-matched controls. Marked neuronal loss (approximately 60%) was identified in AD, although NFTs accounted for only a small proportion of this loss (2.2-17.2%, mean 8.1%). Analysis of NFT accumulation with duration of dementia showed a linear relationship, supporting the belief that NFTs progressively accumulate with time.

Entities:  

Mesh:

Year:  2001        PMID: 11904757     DOI: 10.1007/s00401-001-0477-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  53 in total

1.  Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain.

Authors:  Si-Eun Yoo; Liuji Chen; Ren Na; Yuhong Liu; Carmen Rios; Holly Van Remmen; Arlan Richardson; Qitao Ran
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling.

Authors:  Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 3.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 4.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

5.  Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration.

Authors:  Peter Filipcik; Martin Cente; Gabriela Krajciova; Ivo Vanicky; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2009-03-05       Impact factor: 5.046

6.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Authors:  Melissa E Murray; Neill R Graff-Radford; Owen A Ross; Ronald C Petersen; Ranjan Duara; Dennis W Dickson
Journal:  Lancet Neurol       Date:  2011-07-27       Impact factor: 44.182

7.  Ginsenoside Rg1 decreases neurofibrillary tangles accumulation in retina by regulating activities of neprilysin and PKA in retinal cells of AD mice model.

Authors:  Yanhui He; Haijun Zhao; Guanfang Su
Journal:  J Mol Neurosci       Date:  2013-11-28       Impact factor: 3.444

Review 8.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

9.  Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein.

Authors:  Martin Cente; Stanislava Mandakova; Peter Filipcik
Journal:  Cell Mol Neurobiol       Date:  2009-03-17       Impact factor: 5.046

10.  Cardiac autonomic modulation and cognitive status in Alzheimer's disease.

Authors:  Maria Alice de Vilhena Toledo; Luiz Fernando Junqueira
Journal:  Clin Auton Res       Date:  2009-10-15       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.